Venture Strategy

Our flagship venture strategy, Nexus, invests in privately held breakthrough biomedical technology companies at all stages, from seed to crossover.  

We focus on companies developing drugs, devices, diagnostics, and data-driven insights in which we have conviction on both the scientific and clinical value propositions as well as the business and financial value propositions.
learn more

Portfolio Managers

George C. Petrocheilos
Managing Partner
R. Jacob Vogelstein, Ph.D.
Managing Partner
learn more

WHAT WE SEEK

world-class founders
Transformative Technology
strong ip
experienced management
top-tier co-investors
contact us